Cavendish Hydrogen (CAVEN) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
9 Jul, 2026Executive summary
Completed spin-off and listed independently on the Oslo Stock Exchange as of June 12, 2024.
Achieved a record high of seven hydrogen station installations in Q2 2024, totaling nine for the first half of the year.
Revenue for Q2 2024 reached EUR 9.2 million, up 38% year-over-year, driven by station completions and higher equipment sales.
Acquired a strategically located site for high-capacity pilot station testing near Herning, Denmark.
Cash balance at quarter end was EUR 53.6 million, supported by a capital increase from Nel ASA.
Financial highlights
Q2 2024 revenue: EUR 9.2 million (Q2 2023: EUR 6.7 million); H1 2024 revenue: EUR 18.9 million (H1 2023: EUR 13.6 million).
Q2 2024 EBITDA: EUR -6.6 million, with adjusted EBITDA at EUR -4.0 million after non-recurring IPO costs.
Net loss for Q2 2024 was EUR -7.9 million, improved from EUR -10.3 million in Q2 2023.
Order intake in Q2 2024 was EUR 5.1 million, down from EUR 16.8 million in Q2 2023; order backlog at quarter end was EUR 25.7 million, down 39% year-over-year.
Net cash flow from operating activities in Q2 2024 was EUR -15.5 million.
Outlook and guidance
Next-generation high-capacity hydrogen fueling stations for heavy-duty vehicles expected to be available for sale in 2025.
Profitability is expected to be achieved through increased volumes and the introduction of the next-generation product.
No specific guidance provided on timing for positive EBIT.
Cavendish aims to capture 15% of the high-capacity hydrogen fueling market in Europe and the Americas over time.
Positioned to capture growth from EU's AFIR regulation, with 428 high-capacity stations supported by EUR 1.5 billion in subsidies through 2030.
Latest events from Cavendish Hydrogen
- Order intake surged 377% and EUR 4.8M investment boosts funding despite revenue decline.CAVEN
Q1 2026 - Q4 2025 revenue dropped 71%, but record hydrogen volumes and new contracts support future growth.CAVEN
Q4 2025 - Record hydrogen volumes, new European contracts, and cautious outlook amid weak financials.CAVEN
Q3 2025 - Record hydrogen volumes and improved EBITDA, but revenue and order backlog declined sharply.CAVEN
Q2 2025 - Revenue down 19%, EBITDA improved, strong cash at EUR 46.3m, backlog and sentiment weakened.CAVEN
Q3 2024 - Record hydrogen dispensed in Q1 2025, with revenue down and cash position strong.CAVEN
Q1 2025 - Q4 2024 saw record hydrogen dispensed but revenue and order backlog declined sharply.CAVEN
Q4 2024